Valcyte Tablet, Film Coated
Product Images NDC 61269-480

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valcyte (NDC 61269-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation (Valcyte 01)

FDA Label Image

Chemical Structure (Valcyte 02)

Chemical Structure (Valcyte 02)
Chemical structure of valganciclovir hydrochloride, the active ingredient in Valcyte oral powder for solution. The diagram shows the molecular arrangement characteristic of valganciclovir with its hydrochloride component.*
FDA Label Image

Figure 1 (Valcyte 03)

Figure 1 (Valcyte 03)
An instructional diagram showing two components: a bottle assembly including a bottle, bottle adapter, and child resistant cap; and an oral dispenser labeled with plunger, barrel, and tip parts. The image illustrates the parts of a medication bottle and its dosing dispenser.*
FDA Label Image

Figure (Valcyte 04)

Figure (Valcyte 04)
An instructional illustration showing a hand holding a bottle, with an arrow indicating shaking motion and the text 'Shake well', demonstrating how to properly mix the liquid medication before use.*
FDA Label Image

Figure (Valcyte 05)

Figure (Valcyte 05)
A black and white line drawing showing the top of a bottle with an arrow pointing downward towards a tablet or solid form above the bottle opening. A circular arrow surrounds the top of the bottle, indicating a twisting or screwing motion, likely illustrating how to open or close the bottle or how to insert a tablet.*
FDA Label Image

Figure (Valcyte 06)

Figure (Valcyte 06)
An illustration showing an oral dosing syringe with graduated markings from 2 mL to 12 mL, labeled as a dosage indicator. The syringe is intended for measuring liquid medication doses accurately.*
FDA Label Image

Figure (Valcyte 07)

Figure (Valcyte 07)
An instructional illustration showing a hand holding a syringe with an arrow indicating downward pressure on the plunger. The image likely demonstrates how to properly depress the syringe plunger for oral solution administration.*
FDA Label Image

Figure (Valcyte 08)

Figure (Valcyte 08)
An instructional illustration showing a hand inserting a bottle adapter into the opening of a bottle. The diagram indicates proper placement of the adapter, likely related to preparing or administering the oral powder for solution form of Valcyte (valganciclovir hydrochloride).*
FDA Label Image

Figure (Valcyte 09)

Figure (Valcyte 09)
An instructional illustration showing how to withdraw liquid medication from a bottle into a syringe. One hand holds the bottle upside down, while the other hand draws the liquid into a syringe marked with volume measurements up to 12 mL. The image demonstrates proper technique for dosing oral liquid medication.*
FDA Label Image

Figure (Valcyte 10)

Figure (Valcyte 10)
An instructional line drawing showing a hand lifting a syringe filled with liquid out of a bottle, illustrating the process of withdrawing or administering an oral solution.*
FDA Label Image

Figure (Valcyte 11)

Figure (Valcyte 11)
An instructional illustration showing a child receiving oral medication from a syringe held by an adult hand. The child is positioned sideways, with the syringe placed near their mouth for oral administration.*
FDA Label Image

Figure (Valcyte 12)

Figure (Valcyte 12)
A black and white line drawing of a medicine bottle with a screw cap and a curved arrow pointing to the right around the neck of the bottle, suggesting the action of opening or twisting the cap.*
FDA Label Image

Figure (Valcyte 13)

Figure (Valcyte 13)
An instructional illustration showing a water faucet with drops of water falling onto a syringe and a vial. This suggests a step involving adding water to a syringe or vial, likely related to preparing an oral solution.*
FDA Label Image

Figure (Valcyte 14)

Figure (Valcyte 14)
An illustration of a standard oral syringe with a clear barrel marked with measurement graduations and a plunger for dispensing liquid medication. No product branding or labeling is present in the image.*
FDA Label Image

Principal Display Panel (450 mg Bottle Carton)

Principal Display Panel (450 mg Bottle Carton)
Label for Valcyte (valganciclovir) 450 mg tablets showing a package size of 60 tablets. The label includes a caution about strict adherence to dosage and states not to break or crush tablets. The labeler is CHEPLAPHARM. The NDC number shown is 61269-480-60.*
FDA Label Image

Principal Display Panel (100 mL Bottle Carton)

Principal Display Panel (100 mL Bottle Carton)
Label for Valcyte (valganciclovir) oral solution, 50 mg/mL concentration. The label notes that each mL of constituted oral solution contains 50 mg valganciclovir free base. The container size is 100 mL (3.4 fl oz). The label includes the NDC 61269-485-10 and shows the CHEPLAPHARM logo with an Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.